Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic control of mesenchymal stem cells orchestrates bone regeneration. | Front Endocrinol (Lausanne) | 2023 | 36950693 | PubTator, text mining | PubMed |
| Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks. | Oncogene | 2023 | 36944729 | PubTator, text mining | PubMed |
| Emerging role of exosomes in vascular diseases. | Front Cardiovasc Med | 2023 | 36937921 | PubTator, text mining | PubMed |
| Glycocalyx engineering with heparan sulfate mimetics attenuates Wnt activity during adipogenesis to promote glucose uptake and metabolism. | J Biol Chem | 2023 | 36931394 | PubTator, text mining | PubMed |
| The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors. | Int J Biol Sci | 2023 | 36923930 | PubTator, text mining | PubMed |
| KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8+ T-cell-dependent antitumor immunity. | Theranostics | 2023 | 36923542 | PubTator, text mining | PubMed |
| The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives. | Mol Med | 2023 | 36918822 | PubTator, text mining | PubMed |
| Dynamics of histone acetylation during human early embryogenesis. | Cell Discov | 2023 | 36914622 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients. | Int J Mol Sci | 2023 | 36902193 | PubTator, text mining | PubMed |
| Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology. | Int J Mol Sci | 2023 | 36902112 | PubTator, text mining | PubMed |
| Editorial: The development of lethal prostate cancer. | Front Cell Dev Biol | 2023 | 36895791 | PubTator, text mining | PubMed |
| Construction of a TTN Mutation-Based Prognostic Model for Evaluating Immune Microenvironment, Cancer Stemness, and Outcomes of Colorectal Cancer Patients. | Stem Cells Int | 2023 | 36895786 | PubTator, text mining | PubMed |
| The role of bile acid in intestinal metaplasia. | Front Physiol | 2023 | 36891144 | PubTator, text mining | PubMed |
| Comprehensive characterization of the embryonic factor LEUTX. | iScience | 2023 | 36876139 | PubTator, text mining | PubMed |
| Integrated transcriptional analysis reveals macrophage heterogeneity and macrophage-tumor cell interactions in the progression of pancreatic ductal adenocarcinoma. | BMC Cancer | 2023 | 36864399 | PubTator, text mining | PubMed |
| Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities. | Mol Ther Oncolytics | 2023 | 36860815 | PubTator, text mining | PubMed |
| Role of Circulating Exosomes in Cerebrovascular Diseases: A Comprehensive Review. | Curr Neuropharmacol | 2023 | 36847232 | PubTator, text mining | PubMed |
| An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma. | Cancer Sci | 2023 | 36840413 | PubTator, text mining | PubMed |
| Biochemical Activation and Regulatory Functions of Trans-Regulatory KLF14 and Its Association with Genetic Polymorphisms. | Metabolites | 2023 | 36837818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=31